论文部分内容阅读
本文报道作者对肝胆及其他疾病患者血清腺苷脱氨酶(ADA)的测定结果,以探讨其对黄疸及肝纤维化的诊断价值。研究对象包括急性黄疸型肝炎、慢性持续性肝炎(CPH)、慢性活动性肝炎(CAH)、肝硬化、肝癌、肝外阻塞性黄疸及其他非肝胆疾病共228例,同时观察血清ADA、胆红素、谷草转氨酶(GOT)、谷丙转氨酶(GPT)、碱性磷酸酶(AKP)等。结果表明:血清ADA在阻塞性黄疸组为19.1±6.4u,阳性率为16.7％,均明显低于黄疸肝炎组(26.9±10.5u,57.3％)及肝硬化伴黄疸者(38.79±19.75u,80.9
This article reports the results of the determination of serum adenosine deaminase (ADA) in patients with hepatobiliary and other diseases in order to investigate its diagnostic value of jaundice and liver fibrosis. A total of 228 patients with acute jaundice hepatitis, chronic persistent hepatitis (CPH), chronic active hepatitis (CAH), cirrhosis, liver cancer, extrahepatic obstructive jaundice and other non-hepatobiliary diseases were observed. Serum ADA, Aspartate aminotransferase (GOT), alanine aminotransferase (GPT), alkaline phosphatase (AKP) and the like. The results showed that the serum ADA level in obstructive jaundice group was 19.1 ± 6.4u and the positive rate was 16.7%, which were significantly lower than those in jaundice hepatitis group (26.9 ± 10.5u, 57.3%) and cirrhosis with jaundice (38.79 ± 19.75u, 80.9